Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery
- PMID: 20836623
- DOI: 10.1517/17425247.2010.514604
Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery
Abstract
Importance of the field: This review aims to provide an overview of state-of-the-art chitosan-based nanosized carriers for the delivery of therapeutic agents. Chitosan nanocarriers are smart delivery systems owing to the possibility of their property alterations with various approaches, which would confer them with the possibility of spatiotemporal delivery features.
Areas covered in this review: The focus of this review is principally on those aspects that have not often been addressed in other reviews. These include the influence of physicochemical properties of chitosan on delivery mechanisms and chitosan modification with a variety of ligand moieties specific for cell surface receptors to increase recognition and uptake of nanocarriers into cells through receptor-mediated endocytosis. Multiple examples that demonstrate the advantages of chitosan-based nanocarriers over other delivery systems of therapeutic agents are highlighted. Particular emphasis is given to the alteration of material properties by functionalization or combination with other polymers for their specific applications. Finally, structural and experimental parameters influencing transfection efficiency of chitosan-based nanocarriers are presented for both in vitro and in vivo gene delivery.
What the reader will gain: The readers will acquire knowledge of parameters influencing the properties of the chitosan-based nanocarriers for delivery of therapeutic agents (genetic material or drugs) in vitro and in vivo. They will get a better idea of the strategies to be adapted to tune the characteristics of chitosan and chitosan derivatives for specific delivery applications.
Take home message: Chitosan is prone to chemical and physical modifications, and is very responsive to environmental stimuli such as temperature and pH. These features make chitosan a smart material with great potential for developing multifunctional nanocarrier systems to deliver large varieties of therapeutic agents administrated in multiple ways with reduced side effects.
Similar articles
-
Chitosan-based drug nanocarriers: where do we stand?J Control Release. 2012 Jul 20;161(2):496-504. doi: 10.1016/j.jconrel.2012.03.017. Epub 2012 Mar 23. J Control Release. 2012. PMID: 22480607 Review.
-
Development of new chitosan/carrageenan nanoparticles for drug delivery applications.J Biomed Mater Res A. 2010 Mar 15;92(4):1265-72. doi: 10.1002/jbm.a.32466. J Biomed Mater Res A. 2010. PMID: 19322874
-
Ultrapure chitosan oligomers as carriers for corneal gene transfer.Biomaterials. 2010 Mar;31(7):1814-20. doi: 10.1016/j.biomaterials.2009.10.031. Epub 2009 Oct 30. Biomaterials. 2010. PMID: 19879644
-
Chitosan nanoparticles for drug delivery to the eye.Expert Opin Drug Deliv. 2009 Mar;6(3):239-53. doi: 10.1517/17425240902762818. Expert Opin Drug Deliv. 2009. PMID: 19290841 Review.
-
Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.Drug Dev Ind Pharm. 2009 Nov;35(11):1348-55. doi: 10.3109/03639040902939197. Drug Dev Ind Pharm. 2009. PMID: 19832635
Cited by
-
Synthesis of chitosan nanoparticles (CSNP): effect of CH-CH-TPP ratio on size and stability of NPs.Front Chem. 2024 Nov 15;12:1469271. doi: 10.3389/fchem.2024.1469271. eCollection 2024. Front Chem. 2024. PMID: 39618968 Free PMC article.
-
Nanotechnology-Based Drug Delivery Systems for Treating Acute Kidney Injury.ACS Biomater Sci Eng. 2024 Oct 14;10(10):6078-6096. doi: 10.1021/acsbiomaterials.4c01385. Epub 2024 Sep 3. ACS Biomater Sci Eng. 2024. PMID: 39226188 Free PMC article. Review.
-
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.Nanomedicine (Lond). 2013 Dec;8(12):1943-54. doi: 10.2217/nnm.12.200. Epub 2013 Feb 28. Nanomedicine (Lond). 2013. Retraction in: Nanomedicine (Lond). 2025 May;20(9):1071. doi: 10.1080/17435889.2025.2488633. PMID: 23448245 Free PMC article. Retracted.
-
In vivo methods for acute modulation of gene expression in the central nervous system.Prog Neurobiol. 2018 Sep;168:69-85. doi: 10.1016/j.pneurobio.2018.04.008. Epub 2018 Apr 22. Prog Neurobiol. 2018. PMID: 29694844 Free PMC article. Review.
-
Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.Eur J Integr Med. 2013 Apr 1;5(2):126-140. doi: 10.1016/j.eujim.2012.11.002. Eur J Integr Med. 2013. PMID: 23795222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials